Acute intracerebral hemorrhage (ICH) complicated by hyperglycemia is associated with aggravation of post-stroke inflammation, leading to exacerbation of brain edema and predicting poor neurological outcomes and higher mortality of patients. Osteopontin (OPN) is a neuroprotective glycoprotein, which is able to attenuate brain injury induced by hemorrhagic stroke. In the current study we investigated whether OPN will decrease the inflammatory post-ICH response as well as attenuate brain edema and neurological deficits in hyperglycemic rats. We employed a collagenase model of ICH on male SpragueDawley rats (n ¼ 148) rats and 50% of Dextrose was injected intraperitoneally (i.p) 3 h after ICH (ICH þ HG). Intranasal administration of recombinant OPN (rOPN) was performed 1 h after ICH. The development of brain injury was evaluated by brain water content (BWC) and neurological deficits, western blot and immunohistochemistry study. Small interfering ribonucleic acid (siRNA) for integrin-b1 receptor and a JAK2 agonist, Coumermycin A1 (C-A1), were used for detailed investigation of the molecular pathway. The administration of OPN (3 mg) significantly improved neurobehavior and increased expression of OPN and integrin-b1 receptor in the brain followed with decrease of neutrophil infiltration, JAK2, STAT1, TNF-a, IL-1b, MMP-9 and brain edema in the ICH þ HG þ OPN rats compared with ICH þ HG rats. The effects of OPN were reversed by the intervention of intergrin-b1 siRNA and C-A1. In conclusion, rOPN attenuated ICH-induced brain inflammation in hyperglycemic rats, leading to attenuation of brain edema and improving neurological functions. Effects of rOPN were mediated at least partly by integrinb1 induced inhibition of JAK2/STAT1 pathway.
Introduction
Brain inflammation is a major pathophysiological factor, which significantly contributes to the development of secondary brain injury and consequently to high mortality and morbidity of patients after intracerebral hemorrhage (ICH). Shortly after ICH, activated microglia increased production of such inflammatory mediators as TNF-a (Rendevski et al., 2017; Wang et al., 2003) . TNF-a can directly disturb function of the bloodebrain barrier (BBB) allowing the blood elements to infiltrate the brain, aggravating the brain inflammation after ICH (Kawanishi et al., 2008; Lv et al., 2010) . The cumulative inflammatory effects induced by microglia, toxic elements of blood degradation and immune cells, infiltrated brain, results in development of brain injury and neurological dysfunctions after ICH. Therapeutic strategies, which are able to attenuated post-ICH inflammation, are promising approaches, which can decrease mortality and morbidity of ICH patients (Omoyinmi et al., 2017) .
Osteopontin (OPN) is an inducible pleiotropic extracellular matrix glycoprotein, which physiologically interacts with several subforms of integrin-b1 (Uede, 2011) . Upon this interaction OPN regulates development of numerous diseases, between others OPN attenuates development of secondary brain injury after hemorrhagic stroke (Suzuki et al., 2010; Wu et al., 2016) . However, a role of OPN on the neuroinflammation has never been studied previously in ICH. In this study, we aimed to investigate whether intranasally administrated recombinant osteopotin (rOPN) will attenuate inflammation and infiltration of neutrophils, resulting in attenuation of perihematomal edema formation in the brain and consequently improving neurologic functions of hyperglycemic rats after ICH. Furthermore, we explored molecular mechanisms underlying OPN induced protection.
Materials and methods

Animals
All experimental procedures were performed following a corresponding study protocol approved by the Institutional Animal Care and Use Committee (IACUC) of Loma Linda University in accordance with the NIH Guide for the Care and Use of Laboratory Animals. A total of 148 adult male Sprague-Dawley rats (weight 280e320 g, Charles River, Wilmington, MA) housed in a light and temperature controlled room with sufficient food and water were used in this study.
Experimental design
To determine expression of the key protein related to integrinb1 dependent mechanism in hyperglycemic rats after ICH (ICH þ HG), 47 rats were randomly assigned into 6 groups in time course experiments: sham (n ¼ 6) and ICH þ HG at 6, 12, 24, 48, 72 h after ICH induction. 50% Dextrose (8 ml/kg, Hospira, Inc.) was injected intraperitoneally (i.p) 3 h after ICH. Western blots were used to detect the protein expression of integrin-b1, OPN, p-JAK2, JAK2, p-STAT1 and STAT1 in the right hemisphere of the brain. Cellular localization of integrin-b1 in microglia and astrocytes was detected with immunohistochemistry (IHC) staining after 24 h after in sham and ICH þ HG groups (n ¼ 3 per group).
Next, to evaluate the effect of rOPN after ICH þ HG, 53 rats were randomly divided into 8 groups at 24 h and 72 h after ICH induction. For 24 h, there are five subgroups: sham (n ¼ 6), ICH þ HG þ vehicle (30 mL of sterile 0.9% NaCl; n ¼ 7), ICH þ HG þ rOPN 1 mg (1 mg in 30 mL of sterile 0.9% NaCl; n ¼ 6), ICH þ HG þ rOPN 3 mg (3 mg in 30 mL of sterile 0.9% NaCl; n ¼ 7), ICH þ HG þ rOPN 9 mg (9 mg in 30 mL of sterile 0.9% NaCl; n ¼ 6). For 72 h, there are three subgroups: sham
. Neurological scores and brain water content were assessed respectively at 24 h and 72 h after ICH.
Finally, to determine molecular mechanism, 48 rats were randomly assigned into 5 groups:
A1 (C-A1) (100 mg/kg, Santa Cruz) (n ¼ 11). C-A1, a JAK2 agonist, and sterile 0.9% NaCl were administered i.p 1 h after ICH induction. Western blots and MPO staining were performed 24 h after ICH in all groups.
Animal model and experimental protocol
One hundred and forty-eight, 8-week-old male SD rats (weight 280e320 g, Charles River, Wilmington, MA) were used. ICH rats model was performed by collagenase injection as reported previously (Manaenko et al., 2018) . 50% Dextrose was injected intraperitoneally (i.p) 3 h after ICH to induce acute hematoma expansion (Zheng et al., 2015) .
Blood glucose measurement
The level of blood glucose was monitored within 24 h after injecting i.p 50% Dextrose. To this end, the tail vein was punctured and 10 mL of blood was collected. The glucose level was measured using hemoglucometer (Aim Strip Plus Blood Glucose Meter Germanine Laboratories, INC.) Inclusion criteria require a blood glucose level of 175 mg/dl to 300 mg/dl within 24 h after injecting i.p 50% Dextrose.
Measurement of hemorrhagic volume (hemoglobin assay)
The spectrophotometric hemoglobin assay was performed as described before (Lekic et al., 2013) . Extracted brainstem tissue was placed in glass test tubes with 3 ml of PBS and then homogenized for 60 s (Tissue Miser Homogenizer, Fisher Scientific). Ultrasonication for 1 min lysed erythrocyte membranes, the products were centrifuged for 30 min, and Drabkin reagent was added (Sigma-Aldrich) into aliquots of supernatant fluid that reacted for 15 min. Absorbance, using a spectrophotometer (540 nm; Genesis 10uv, Thermo Fisher Scientific), was calculated into a hemorrhagic volume on the basis of a standard curve.
Brain water content (BWC) measurement
Brain water content was measured as previously described . Briefly, mice were decapitated under deep anesthesia. Brains were immediately removed and cut into 4 mm sections around the needle track. Each section was divided into four parts: ipsilateral and contralateral basal ganglia, ipsilateral and contralateral cortex. The cerebellum was collected as an internal control. Each part was weighed on an electronic analytical balance (APX-60, Denver Instrument) and then dried at 100 C for 24 h to determine the dry weight (DW). Brain water content (%) was calculated as [(WW À DW)/WW] Â 100.
Nasal administration of rOPN
Intranasal administration of rOPN was performed 1 h after ICHinduction. Under isoflurane anesthesia, were placed in a supine position and 0.9% NaCl or rOPN dissolved in sterile 0.9% NaCl was administered alternately into the left and right nares, one drop every 2 min over a period of 12 min (Xie et al., 2017) . A total volume of 30 mL was administered. Three different dose of rOPN were tested (1 mg, 3 mg, 9 mg).
Intracerebroventricular injection
Intracerebroventricular (i.c.v) drug administration was performed as reported previously (Ma et al., 2017; Tong et al., 2017) . Briefly, rats were positioned prone in a stereotaxic apparatus under 2.5% isoflurane anesthesia. A burr hole was drilled into the skull according to the following coordinates relative to bregma: 0.92 mm posterior and 1.5 mm lateral. The needle of a 10 mL Hamilton syringe (Microliter 701; Hamilton Company, Reno, NV) was inserted into the left lateral ventricle through the burr hole 3.3 mm below the horizontal plane of bregma. Integrin b1 siRNA (10 mM/10 mL, Santa Cruz, USA) or scrambled siRNA (10 mM/10 mL, Santa Cruz, USA) was infused at the same rate 48 h before ICH induction.
Neurological scores
Twenty-four or 72 h after ICH, the Garcia test was performed by a blinded investigator as previously described with modifications (Manaenko et al., 2011) . The scores given to each of the rats at the completion of the evaluation was the summation of 7 individual test scores (spontaneous activity, symmetry in the movement of four limbs, forepaw outstretching, climbing, body proprioception, response to vibrissae touch, and beam walking). The neurological scoring ranged from 2 (most severe deficit) to 21 (maximum).
Immunohistochemistry staining
The brain tissues were collected at 24 h after ICH. Immunofluorescent staining for brain samples was performed on fixed frozen ultrathin sections as previously described (Zheng et al., 2015) . Primary antibodies used were anti-Integrin-b1 primary antibody (1:200, ab179471, MA, USA), anti-MPO (sc-16128, 1:200, Santa Cruz Biotechnology), anti-GFAP (1:500, ab110062), and anti-Iba-1 (1:100, ab107159). Peri-hemorrhagic area of the brain coronal section was imaged by Leica DMi8 (Leica microsystems, Germany).
Western blot analysis
24 h after surgery, the rats under deep anesthesia were perfused via intracardially with 150 ml of ice cold PBS and brain samples were collected. Protein extraction and Western blots were performed according to the manufacturer's recommendation, as previously reported (Manaenko et al., 2011) . Whole-cell lysates were obtained by gently homogenizing in RIPA lysis buffer (Santa Cruz Biotechnology, Inc., sc-24948) and centrifuging (14,000 g at 4 C for 30 min). The supernatant of the extract was collected, and the protein expression was determined using a detergent compatible assay (Bio-Rad, Dc protein assay). Equal amounts of protein (50 mg)
were loaded and subjected to electrophoresis on an SDS-PAGE gel. After being electrophoresed and transferred to a nitrocellulose membrane, the membrane was blocked and incubated with the primary antibody overnight at 4 C. For an internal control, the same membrane was probed with an antibody against b-actin after being stripped. Secondary antibodies (Santa Cruz Biotechnology) were incubated for 1 h at room temperature. Immunoblots were then probed with an ECL Plus chemiluminescence reagent kit (Amersham Biosciences, Arlington Heights, IL) and visualized with an imaging system (Bio-Rad, Versa Doc, model 4000). Data was analyzed using Image J software. Following primary antibodies used were: OPN (1:1000, sc-21742, Santa Cruz Biotechnology), integrin-b1 (1:1000, ab179471, MA, USA), pJAK2/JAK2 (1:1000, ab32101/ab39636, MA, USA), pSTAT1/STAT1 (1:1000, ab30645/ ab31369, MA, USA), IL-1b (1:1000, ab9722, MA, USA), TNF-a (1:1000, ab6671, MA, USA), MMP-9 (1:500, ab38898, MA, USA), MPO (1:500, sc-16128, Santa Cruz Biotechnology), and b-actin
(1:3000, I-19, Santa Cruz Biotechnology, CA).
Statistical analysis
The analysis of the data was performed using GraphPad Prism and SPSS 22.0 software. Statistical differences between two groups were analyzed using the student's unpaired, two-tailed t-test. Multiple comparisons (without a rating scale) were statistically analyzed with one-way analysis of variance (ANOVA) followed by the Tukey method. Mortality was statistically analyzed with Chisquare test. The data are presented as mean ± SEM. In all statistical analysis, a value of P < 0.05 represents statistical significance.
Results
Mortality
Of the 148 total animals, 21 rats were subjected to sham and 127 rats were subjected to ICH þ HG induction, with total 10 (8%) animals died within 24 h and total 3 (14%) animals died at 72 h after surgery. The animals were divided randomly in each groups. The mortality within 24 h after surgery in this study was as follows in each group: sham, 0% (0 died of 9 rats in time course study); ICH, 13% (5 died of 38 rats in time course study); sham, 0% (0 died of 6); ICH þ HG þ vehicle, 12% (2 died of 17); ICH þ HG þ rOPN, 4% (1 died of 28); ICH þ HG þ Scramble siRNA, 0% (0 died of 9); ICH þ HG þ Integrin-b1 siRNA, 0% (0 died of 9); ICH þ HG þ rOPN þ Coumermycin, 18% (2 died of 11). The mortality at 72 h after surgery in this study was as follows in each group: sham, 0% (0 died of 6); ICH þ HG þ vehicle, 25% (2 died of 8); ICH þ HG þ rOPN, 14% (1 died of 7). (Table 1) .
Ip injection of glucose resulted in increased blood glucose level
Blood glucose peaked 1 h after intraperitoneal injection of 50% dextrose, and returned to the baseline within 4 h, and rOPN had no effect on blood glucose level (Supplemental Fig. 1 ).
Effects of ICH þ HG on the expression of OPN and integrin-b1/ JAK2/STAT1 pathway's proteins
The endogenous expression of OPN was no changes in earlier stages of ICH compared to sham group. At 24 h we observed significant decrease of OPN followed by significantly upregulation of the production at 48 h. The production remained upregulated at 72 h after ICH (Fig. 1A and B) . Similar pattern of expression changes were observed by the integrin-b1. The expression of integrin-b1 was significantly decreased at 24 h and up-regulated at 48 and 72 h after ICH ( Fig. 1 A and C) . Additionally, ratio of p-JAK2 and p-STAT1 to total JAK2 and STAT1, respectively, were significantly increased at 24 h after ICH (Fig. 1 A, D and E) . Furthermore, colocalization of integrin-b1 with microglia (Iba-1) and astrocytes (GFAP) was observed in the perihematoma area of ipsilateral hemisphere after 24 h after ICH induction (Fig. 2) .
Effects of rOPN intranasal administration on the brain injury after ICH
ICH resulted in significant increase of brain water content in the ipsilateral basal ganglia 24 h after ICH (Fig. 3 A) . Consequently significant neurological dysfunctions were observed in all ICH compared to sham operated animals (Fig. 3BeC) . While low dose of OPN was ineffective, but both medium and high doses of OPN significantly decreased ICH-induced brain water content elevation, leading to improvement of neurological functions evaluated by modified Garcia and beam balance tests (Fig. 3AeC) . No significant difference in effects of high and medium doses of OPN was observed. Therefore the medium dose was used to investigate time dependent effects of OPN in further experiments. Compared to sham operated animals the increased brain water content was detected both in ipsilateral basal ganglia and in cortex as evaluated at 72 h after ICH (Fig. 3 D) . OPN attenuated the increase of brain water content, resulting in amelioration of ICH-induced neurological dysfunctions (Fig. 3B and C, E and F) .
Effects of rOPN on the JAK2/STAT1 pathway and neutrophil infiltration
Intranasal administration of rOPN dose-dependently increased OPN expression in brain. While low dose of rOPN (1 mg) had no effect on endogenous OPN expression, medium (3 mg) and high (9 mg) doses of rOPN increased brain OPN expression above level, which was observed in sham operated animals. No difference between medium and high doses of rOPN was observed (Fig. 4 A) . The increase of OPN amount in brain was accompanied with an accumulation of integrin-b1 (Fig. 4 B) . ICH induced an increase ration of phosphorylated/total JAK2 and STAT1. The OPN increase was accompanied with the decrease of phosphorylated to total protein ratio of both JAK2 and STAT1 (Fig. 4C and D, respectively) . Moreover, ICH induced overproduction of TNF-a and Il-1b, which was accompanied with MMP-9 activation (Fig. 4EeG) . rOPN induced inhibition of JAK2/STAT1 pathway resulted in the decrease of TNF-a and Il-1b production (Fig. 4EeF) , which in turn led to dose dependent decrease the ICH-induced overexpression of MMP-9 (Fig. 4 G) . Furthermore, rOPN administration attenuated post-ICH brain infiltration by neutrophils, evaluated by immunostaining and western blot to neutrophils specific protein, MPO (Fig. 5AeC). 3.6. Integrin-b1 siRNA and JAK2 agonist reversed the effect of rOPN While scramble siRNA shown no effect, siRNA induced in-vivo knock down of integrin-b1 resulted in significant down regulation of the integrin-b1 leading to the increase of phosphorylated to total protein ratio of JAK2 and STAT1 (Fig. 6AeC) and aggravating the brain inflammation (Fig. 6DeE) and activating MMP-9 (Fig. 6 F) and to more brain infiltration by neutrophils (representative immunostaining Fig. 7A , evaluation of neutrophils infiltration by western blot Fig. 7AeC ). As expected, an activation of JAK2 by C-A1 had no effect on integrin-b1 expression, however, compared to OPN treated animals, increased ratio of phosphorylated JAK2 to total JAK2, resulting in the increase of ratio of phosphorylated STAT1 to total STAT1. That reversed effects of OPN and increased expression of Il-1b, TNF-a and MMP-9 in post ICH brain (Fig. 6 ) as well as increased the brain infiltration by neutrophils (Fig. 7) in ICH þ HG rats.
Discussion
In this study we demonstrated that intranasally administrated rOPN attenuated the development of secondary brain injury in hyperglycemic rats after ICH. We demonstrated furthermore that protective effects of rOPN are mediated, at least partly, by integrinb1, which was able to attenuated ICH induced activation of JAK2/ STAT1 pathway, decreasing post-ICH inflammation. The acute hyperglycemia is common for the patients with preexisting diabetes. After ICH, however, more than 59% of patients without diabetes show increase blood glucose concentration on admission, and blood glucose level remains upregulated till 72 h after admission in 45% of patients (Bejot et al., 2012; Godoy et al., 2008; Wu et al., 2017) . The high level of glucose is a predisposition for worth neurological outcomes, poor functional recovery at discharge and increased 1-month mortality after ICH (Bejot et al., 2012; Godoy et al., 2008) . In preclinical studies, the combination stroke/hyperglycemia induces bigger hematoma, higher level of inflammation and apoptosis, consequently leading to the aggravation of post-ICH brain injury and neurological dysfunctions (Chiu et al., 2012; Zheng et al., 2015) . The hyperglycemia in animals can be induced by intraperitoneal injection of glucose as we did in current study and before (Zheng et al., 2015) .
We established that ICH increased the endogenous OPN production starting at 48 h after ICH þ HG. That was in agreement with previous publication, demonstrating increase of endogenous OPN production after hemorrhagic stroke in animals and human patients (Nakatsuka et al., 2018; Suzuki et al., 2010) . We hypothesized that the endogenous OPN is able to decrease brain injury and the increase of OPN production is a protective stress reaction of the brain.
That is in agreement with presvious publication, demonstrating that pre-treatment via intracerebroventricular infusion of rOPN 20 min pre-ICH attenuates development of brain edema and improves neurological functions of mice (Wu et al., 2011) . We demonstrated previously that the development of brain edema after experimental ICH is time dependent and reach maximum 24/72 h after ICH (Manaenko et al., 2011) . Free iron accumulation and iron induced oxidative stress peaks at 72 h after ICH (Xi et al., 2006) . Since at this time point the OPN expression peaks, we hypothesized that OPN production increases parallel with the development of brain injury and that earlier increase of OPN expression in brain will prevent the development of brain injury. In order to investigate the potential mechanism of OPN we monitored the expression of integrin-b1 as well as the expression of JAK2 and STAT1. We established that integrin-b1 is expressed in Iba-1 and GFAP positive cells and that ICH induced OPN overproduction was associated with integrin-b1 overproduction at 48e72 h after ICH. That is in agreement with previous findings demonstrating that overproduction of OPN was accompanied with the increased integrin-b1 production (Zou et al., 2013) . Furthermore, it is known that integrin-b1 effects are mediated, at least partly, by its ability to inhibit JAK/STAT pathway (Yan et al., 2017) . To study whether this pathway is relevant in our particular model we first investigated effects of ICH on JAK/STAT expression and activation. While some studies demonstrated that stroke induced activation via phosphorylation of this proteins there are publications demonstrating that stroke can increase the expression of the proteins as well (Justicia et al., 2000; Spudich et al., 2005) . In agreement with these studies we demonstrated that ICH significantly increased both expression and phosphorylation of the STAT1. Similar results, demonstrating that rOPN is able to attenuate ICH induced STAT1 phosphorylation was demonstrated before (Wu et al., 2011) . Additionally, we observed that the JAK2/STAT1 pathway was activated at time point, on which no up-regulation of integrinb1 was observed. The increase of integrin-b1 expression was associated with inhibition of JAK/STAT pathway.
In the next experiment we investigated effects of intranasal administration of recombinant OPN on the development of secondary brain injury and neurological dysfunctions after ICH. The maximal molecular weight of a substance, which can penetrate intact BBB varies, according to different study, from 0.4 till 7.8 kDa (Banks, 2009) . The molecular weight of OPN is 33 kDa, such molecular weight it will not allow rOPN to penetrate BBB. For this reason we have chosen the intranasal route of drug administration.
The intranasal administration is a safe, none invasive and reliable way of high molecular weight drug delivery over the intact BBB. This way of drug administration provides a direct route to the brain. After administration a drug will undergo endocytosis and be transported along olfactory nerves or by extracellular flow through intercellular clefts in the olfactory epithelium and to diffuse into the subarachnoid space (Thorne et al., 1995) . The efficiency of this route of drug administration in pre-experimental animal models was demonstrated before (Wu et al., 2016) . In current study we established that intranasal administration dose dependently increased amount of rOPN in the brain. The maximal increase of OPN amount in the brain was achieved with medium and high dose of the drug. The OPN increase, induced by medium and high OPN dose, was accompanied with amelioration of peri-hematomal brain edema development in ICH treated compared to none-treated animals. The development of brain edema was evaluated by brain water content calculation (Manaenko et al., 2018) . The decrease of brain water content confirmed our working hypothesis, that OPN is able to decrease inflammation and stabilize BBB after ICH. The decrease of brain water content resulted in significant improvement of neurological functions (Manaenko et al., 2011) . Furthermore the improved functions of BBB led to the attenuation of brain infiltration by MPO positive neutrophils.
This results contradict previous funding demonstrating that high OPN is an independent predictor for poor outcome after another kind of hemoragic stroke, a subarachnoid hemorrhage in human patients (Nakatsuka et al., 2018) . It is however worth to mention that authors of this publication measured OPN concentration in plasma. As mentioned before OPN, due to high molecular weight, does not pass BBB and the plasma concentration of the substance does not mirror changes in brain concentration. The patients with high OPN had more prominent neurological dysfunction. With presented data is difficult to understand is a systemic overproduction of OPN a response of organism on more severe brain damage or systemic produced OPN contributes to the development of brain injury after SAH. Furthermore authors determinated that high OPN in blood correlates with development of vasospasm and consequently with delayed cerebral infarction. It is theoretically possible that systemic OPN induced vasospasm and on this way damages post-SAH brain without penetrating BBB. However arise of vasospasm after ICH in unknown and it is unlikely that systemic OPN can induce additionally brain damage after ICH as well. Having said that we admit that the results presented by Nakatsuka et al. clearly indicated that role of OPN in development of brain injury after stroke is not fully understood. Futher investigation, especially of role of OPN on the development of long term brain injury and neurological disfunctions are uregently needed.
To investigate the molecular pathway underlying observed beneficial effects of rOPN, we proved whether OPN is able to affect the integrin-b1 expression and consequently to inhibit JAK2/STAT pathway. While low dose of rOPN had no effect on integrin-b1 expression, medium and high dose of rOPN significantly increased expression of integrin-b1 and inhibited JAK2/STAT1 pathway. It has been demonstrated that JAK/STAT pathway modulates inflammatory response after stroke (Hou et al., 2010; Tao et al., 2015; Wasserman et al., 2007; Zhou et al., 2014) . In agreement with these we observed that rOPN induced inhibition of JAK/STAT pathway significantly attenuated post-ICH overproduction of TGF-a and IL1b. The decrease of inflammatory marker production was, furthermore, associated with less MMP-9 expression and significant attenuated brain infiltration by neutrophils.
To further strong our working hypothesis we induced in vivo knock down of integrin-b1 via i.c.v administration of siRNA. These administration route of siRNA proofed itself as a reliable way for induction of in vivo knock down (Manaenko et al., 2018) . While scramble RNA had not effect on integrin-b1, siRNA induced knock down resulted in significant downregulation of integrin-b1 expression. Knock down of integrin-b1 resulted in turn in activation of JAK2/STAT1 and increased production of IL-1b and MMP-9 as well as aggravated brain inflammation by neurophils.
So far we established that rOPN effects are mediated through JAK2/STAT1 pathway. In the last experiment we examined if activation of JAK2 is able to reverse rOPN effects. To activate JAK2 we employed C-A1, a compound able to induce JAK2 autophosphorylation (Mizuguchi and Hatakeyama, 1998) . Well in agreement with that we observed that C-A1 induced significant increase of phosphorylated/total JAK2 level, which in turn resulted in activation of STAT2. No effects of C-A1 on integrin-b1 expression, confirming that integrin-b1 is an upstream of JAK2.
Furthermore we demonstrated that C-A1 induced activation of JAK2 reversed beneficial effects of rOPN and increased both production of pro-inflammatory factors and brain infiltration by neutrophils.
In conclusion, rOPN attenuated ICH-induced brain inflammation in hyperglycemic rats, leading to attenuation of brain edema, and improving neurological functions. Effect of rOPN were mediated at least partly by integrin-b1 and integrin-b1 induced inhibition of JAK2/STAT1 pathway.
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